Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Thermo Fisher Scientific Inc. (TMO) Insider Trading Activity
Healthcare • Diagnostics & Research • 122,000 employees
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Total Value
-$63,771,266.28
Total Shares
5,474
Average Trade Value
-$498,213.02
Most Active Insider
Casper Marc N
Total Activity: $64,570,206
Largest Single Transaction
$9,732,123
by Lowery Frederick M. on Feb 24, 2025
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Executive Vice President
Officer
|
Mar 3, 2025 | 1,780 | $945,038 | 19,279 (-9.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Feb 28, 2025 | 3,825 | $2,023,272 | 115,173 (-3.3%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Feb 28, 2025 | 812 | $429,516 | 15,035 (-5.4%) | Payment of Exercise Price | |
|
VP Chief Accounting Officer
Officer
|
Feb 28, 2025 | 52 | $27,506 | 2,305 (-2.3%) | Payment of Exercise Price | |
|
Executive Vice President COO
Officer
|
Feb 28, 2025 | 1,125 | $595,080 | 24,441 (-4.6%) | Payment of Exercise Price | |
|
VP Chief Accounting Officer
Officer
|
Feb 28, 2025 | 4 | $2,116 | 2,301 (-0.2%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Feb 28, 2025 | 636 | $336,419 | 21,059 (-3.0%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Feb 28, 2025 | 244 | $129,066 | 21,804 (-1.1%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Feb 28, 2025 | 109 | $57,657 | 21,695 (-0.5%) | Payment of Exercise Price | |
|
VP Chief Accounting Officer
Officer
|
Feb 28, 2025 | 14 | $7,405 | 2,357 (-0.6%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Feb 28, 2025 | 960 | $507,802 | 23,466 (-4.1%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Feb 28, 2025 | 332 | $175,615 | 24,427 (-1.4%) | Payment of Exercise Price | |
|
Sr. VP and Chief Hr Officer
Officer
|
Feb 28, 2025 | 140 | $74,054 | 16,478 (-0.8%) | Payment of Exercise Price | |
|
VP Chief Accounting Officer
Officer
|
Feb 28, 2025 | 27 | $14,282 | 2,371 (-1.1%) | Payment of Exercise Price | |
|
Executive Vice President COO
Officer
|
Feb 28, 2025 | 432 | $228,511 | 25,566 (-1.7%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Feb 28, 2025 | 208 | $110,024 | 15,847 (-1.3%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Feb 28, 2025 | 475 | $251,256 | 16,056 (-3.0%) | Payment of Exercise Price | |
|
Chairman CEO
Director, Officer
|
Feb 28, 2025 | 1,522 | $805,077 | 118,999 (-1.3%) | Payment of Exercise Price | |
|
Sr. VP and Chief Hr Officer
Officer
|
Feb 28, 2025 | 255 | $134,885 | 16,223 (-1.6%) | Payment of Exercise Price | |
|
SVP and General Counsel
Officer
|
Feb 28, 2025 | 128 | $67,707 | 14,846 (-0.9%) | Payment of Exercise Price | |
|
SVP and General Counsel
Officer
|
Feb 28, 2025 | 255 | $134,885 | 14,591 (-1.7%) | Payment of Exercise Price | |
|
Sr. VP and CFO
Officer
|
Feb 28, 2025 | 584 | $308,913 | 34,135 (-1.7%) | Payment of Exercise Price | |
|
Sr. VP and CFO
Officer
|
Feb 28, 2025 | 1,032 | $545,887 | 33,103 (-3.1%) | Payment of Exercise Price | |
|
Executive Vice President
Officer
|
Feb 24, 2025 | 18,300 | $3,855,444 | 35,254 (+51.9%) | Exercise/Conversion | |
|
Executive Vice President
Officer
|
Feb 24, 2025 | 18,300 | $9,732,123 | 16,954 (-107.9%) | Sale | |
|
VP Chief Accounting Officer
Officer
|
Feb 19, 2025 | 474 | $0 | 2,431 (+19.5%) | Grant | |
|
Sr. VP and Chief Hr Officer
Officer
|
Feb 19, 2025 | 871 | $10,000 | 14,204 (+6.1%) | Grant | |
|
Sr. VP and Chief Hr Officer
Officer
|
Feb 19, 2025 | 2,611 | $0 | 16,815 (+15.5%) | Grant | |
|
Executive Vice President
Officer
|
Feb 19, 2025 | 1,638 | $10,000 | 11,911 (+13.8%) | Grant | |
|
Director
|
Feb 19, 2025 | 16 | $8,449 | 14,252 (-0.1%) | Sale | |
|
Executive Vice President
Officer
|
Feb 19, 2025 | 5,043 | $0 | 16,954 (+29.7%) | Grant | |
|
Executive Vice President COO
Officer
|
Feb 19, 2025 | 7,418 | $0 | 26,632 (+27.9%) | Grant | |
|
Executive Vice President
Officer
|
Feb 19, 2025 | 4,747 | $0 | 22,398 (+21.2%) | Grant | |
|
Sr. VP and CFO
Officer
|
Feb 19, 2025 | 1,533 | $10,000 | 28,828 (+5.3%) | Grant | |
|
VP Chief Accounting Officer
Officer
|
Feb 19, 2025 | 157 | $0 | 1,957 (+8.0%) | Grant | |
|
Executive Vice President
Officer
|
Feb 19, 2025 | 1,568 | $10,000 | 17,651 (+8.9%) | Grant | |
|
Executive Vice President COO
Officer
|
Feb 19, 2025 | 2,231 | $10,000 | 19,214 (+11.6%) | Grant | |
|
Sr. VP and CFO
Officer
|
Feb 19, 2025 | 6,409 | $0 | 35,237 (+18.2%) | Grant | |
|
Director
|
Feb 19, 2025 | 95 | $10,000 | 95 (+100.0%) | Grant | |
|
Chairman CEO
Director, Officer
|
Feb 19, 2025 | 23,736 | $0 | 122,177 (+19.4%) | Grant | |
|
Executive Vice President
Officer
|
Feb 19, 2025 | 2,056 | $10,000 | 18,418 (+11.2%) | Grant | |
|
Executive Vice President
Officer
|
Feb 19, 2025 | 6,823 | $0 | 25,241 (+27.0%) | Grant | |
|
SVP and General Counsel
Officer
|
Feb 19, 2025 | 2,611 | $0 | 15,156 (+17.2%) | Grant | |
|
Sr. VP and CFO
Officer
|
Feb 4, 2025 | 9,825 | $2,495,452 | 37,120 (+26.5%) | Exercise/Conversion | |
|
Sr. VP and CFO
Officer
|
Feb 4, 2025 | 9,825 | $5,753,422 | 27,295 (-36.0%) | Sale | |
|
Executive Vice President
Officer
|
Feb 4, 2025 | 300 | $175,677 | 16,362 (-1.8%) | Sale | |
|
Sr. VP and CFO
Officer
|
Feb 3, 2025 | 9,825 | $2,495,452 | 37,120 (+26.5%) | Exercise/Conversion | |
|
Sr. VP and CFO
Officer
|
Feb 3, 2025 | 9,825 | $5,827,502 | 27,295 (-36.0%) | Sale | |
|
Director
|
Dec 9, 2024 | 4 | $2,144 | 14,268 (+0.0%) | Purchase | |
|
Chairman CEO
Director, Officer
|
Dec 3, 2024 | 400 | $211,468 | 110,791 (-0.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 3, 2024 | 400 | $211,812 | 110,391 (-0.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 3, 2024 | 1,345 | $714,034 | 109,046 (-1.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 3, 2024 | 3,352 | $1,783,398 | 105,694 (-3.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 3, 2024 | 3,448 | $1,837,922 | 102,246 (-3.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 3, 2024 | 5 | $2,674 | 101,191 (-0.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 3, 2024 | 1,050 | $560,648 | 101,196 (-1.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 2, 2024 | 400 | $212,708 | 112,191 (-0.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 2, 2024 | 500 | $264,010 | 120,691 (-0.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 2, 2024 | 4,917 | $2,606,256 | 113,350 (-4.3%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 2, 2024 | 759 | $402,961 | 112,591 (-0.7%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 2, 2024 | 600 | $319,902 | 111,591 (-0.5%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 2, 2024 | 2,424 | $1,283,072 | 118,267 (-2.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Dec 2, 2024 | 400 | $213,696 | 111,191 (-0.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 8, 2024 | 1,258 | $692,994 | 22,350 (-5.6%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 8, 2024 | 2,481 | $1,374,176 | 14,908 (-16.6%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 8, 2024 | 1,651 | $911,583 | 20,699 (-8.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 8, 2024 | 3,310 | $1,830,562 | 17,389 (-19.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 8, 2024 | 300 | $166,449 | 14,608 (-2.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 7, 2024 | 400 | $225,260 | 23,608 (-1.7%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 7, 2024 | 1,401 | $782,346 | 25,690 (-5.5%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 7, 2024 | 900 | $505,206 | 24,008 (-3.7%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 7, 2024 | 2,126 | $1,182,269 | 30,443 (-7.0%) | Sale | |
|
Director
|
Nov 7, 2024 | 16 | $8,894 | 14,264 (+0.1%) | Purchase | |
|
Chairman CEO
Director, Officer
|
Nov 7, 2024 | 1,039 | $576,967 | 32,569 (-3.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 7, 2024 | 3,352 | $1,868,103 | 27,091 (-12.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 7, 2024 | 782 | $437,443 | 24,908 (-3.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 1,880 | $1,050,676 | 38,600 (-4.9%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 1,188 | $656,905 | 41,880 (-2.8%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 540 | $297,805 | 43,068 (-1.3%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 600 | $332,322 | 41,280 (-1.5%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 400 | $221,992 | 40,880 (-1.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 400 | $223,092 | 40,480 (-1.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 2,055 | $1,152,444 | 34,274 (-6.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 2,271 | $1,271,283 | 36,329 (-6.3%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 566 | $317,888 | 33,708 (-1.7%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 6, 2024 | 100 | $56,768 | 33,608 (-0.3%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 1,491 | $830,696 | 124,950 (-1.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 600 | $336,180 | 121,291 (-0.5%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 100 | $55,080 | 126,941 (-0.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 5,850 | $1,232,478 | 127,041 (+4.6%) | Exercise/Conversion | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 100 | $55,214 | 126,741 (-0.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 100 | $56,319 | 121,191 (-0.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 1,307 | $730,639 | 121,891 (-1.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 300 | $166,503 | 126,441 (-0.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 100 | $55,159 | 126,841 (-0.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Nov 1, 2024 | 1,752 | $977,879 | 123,198 (-1.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 31, 2024 | 2,969 | $1,632,861 | 122,741 (-2.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 31, 2024 | 3,625 | $1,990,415 | 125,710 (-2.9%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 31, 2024 | 10,000 | $2,106,800 | 131,191 (+7.6%) | Exercise/Conversion | |
|
Chairman CEO
Director, Officer
|
Oct 31, 2024 | 994 | $543,539 | 129,612 (-0.8%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 31, 2024 | 585 | $319,398 | 130,606 (-0.4%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 31, 2024 | 277 | $151,685 | 129,335 (-0.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 31, 2024 | 1,550 | $854,128 | 121,191 (-1.3%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 30, 2024 | 120 | $65,761 | 131,071 (-0.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 30, 2024 | 3,029 | $1,675,279 | 121,369 (-2.5%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 30, 2024 | 3,115 | $1,720,352 | 124,398 (-2.5%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 30, 2024 | 178 | $98,576 | 121,191 (-0.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 30, 2024 | 2,050 | $1,128,915 | 127,513 (-1.6%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 30, 2024 | 1,508 | $829,385 | 129,563 (-1.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 30, 2024 | 10,000 | $2,106,800 | 131,191 (+7.6%) | Exercise/Conversion | |
|
Chairman CEO
Director, Officer
|
Oct 29, 2024 | 10,000 | $2,106,800 | 131,191 (+7.6%) | Exercise/Conversion | |
|
Chairman CEO
Director, Officer
|
Oct 29, 2024 | 3,792 | $2,087,155 | 125,066 (-3.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 29, 2024 | 2,675 | $1,475,343 | 122,391 (-2.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 29, 2024 | 952 | $521,829 | 130,239 (-0.7%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 29, 2024 | 1,381 | $758,915 | 128,858 (-1.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 29, 2024 | 1,100 | $607,651 | 121,291 (-0.9%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 29, 2024 | 100 | $55,321 | 121,191 (-0.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 28, 2024 | 1,165 | $649,371 | 121,591 (-1.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 28, 2024 | 3,294 | $1,824,151 | 124,447 (-2.6%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 28, 2024 | 305 | $169,190 | 124,142 (-0.2%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 28, 2024 | 10,000 | $2,106,800 | 131,191 (+7.6%) | Exercise/Conversion | |
|
Chairman CEO
Director, Officer
|
Oct 28, 2024 | 1,386 | $770,574 | 122,756 (-1.1%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 28, 2024 | 1,300 | $717,444 | 129,891 (-1.0%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 28, 2024 | 2,150 | $1,188,800 | 127,741 (-1.7%) | Sale | |
|
Chairman CEO
Director, Officer
|
Oct 28, 2024 | 400 | $223,380 | 121,191 (-0.3%) | Sale | |
|
Executive Vice President
Officer
|
Oct 25, 2024 | 300 | $168,048 | 16,662 (-1.8%) | Sale | |
|
SVP and General Counsel
Officer
|
Oct 25, 2024 | 2,000 | $1,120,320 | 12,735 (-15.7%) | Sale | |
|
SVP and General Counsel
Officer
|
Oct 25, 2024 | 2,000 | $421,360 | 14,735 (+13.6%) | Exercise/Conversion |